Characteristics of Bone Metabolism Markers During the Healing of Osteoporotic Versus Nonosteoporotic Metaphyseal Long Bone Fractures: a Matched Pair Analysis

Overview

Journal Eur J Trauma Emerg Surg

Specialties Critical Care
Emergency Medicine

Date 2016 Jan 28

PMID 26816128

Citations 3

Authors

L Kolios

M Hitzler

A Moghaddam

C Takur

H Schmidt-Gayk

B Honer

M Lehnhardt

P Grutzner

C Wolfl

Affiliations

Soon will be listed here.

Abstract

Purpose: The activity and metabolism of fracture healing can be monitored quantitatively by measuring bone turnover markers (BTMs) in serum or urine. However, in osteoporotic bone, the exact metabolism processes during the healing of metaphyseal fractures remain unknown. There is no diagnostic approach which currently allows dynamic insight into the fracture healing processes in order to monitor the progression of healing and to assist in therapeutic decision making.

Methods: Between March 2007 and February 2009, 30 patients over 50 years of age who suffered a metaphyseal fracture were included in our study. The levels of the osteoanabolic marker BAP (bone-specific alkaline phosphatase) and osteocatabolic marker β-CTX [crosslinked C-(CTX)-telopeptide-of-type-I-collagen] were monitored during the fracture healing of osteoporotic and nonosteoporotic fractures for a duration of 8 weeks.

Results: After an initial decrease of BAP in the first week, the BAP level steadily increased through the fourth week in both groups. The levels of BAP in the osteoporotic group surpassed the healthy group. β-CTX steadily increased in healthy bone up to the fourth week; in osteoporotic bone, β-CTX first increased and, thereafter, decreased from the first week onwards.

Conclusions: In this work, the first molecular biological aspects of osteoporotic fracture healing have been uncovered, helping to explain the mechanisms of delayed fracture healing in osteoporotic bone. The early decrease of reduced β-CTX as well as elevated BAP during the healing process may be the first aspects within the delayed healing of osteoporotic bone. Further studies are necessary in order to achieve more detailed insight to fracture healing and to ascertain the progression of fracture healing as being essential (criteria) for therapeutic decision making.

Citing Articles

Correction: Characteristics of bone turnover in the long bone metaphysis fractured patients with normal or low Bone Mineral Density (BMD).

Wolfl C, Schweppenhauser D, Guhring T, Takur C, Honer B, Kneser U PLoS One. 2022; 17(6):e0270079.

PMID: 35696449 PMC: 9191733. DOI: 10.1371/journal.pone.0270079.

Clinical Utility of Biochemical Marker of Bone Turnover: Fracture Risk Prediction and Bone Healing.

Yoon B, Yu W J Bone Metab. 2018; 25(2):73-78.

PMID: 29900156 PMC: 5995756. DOI: 10.11005/jbm.2018.25.2.73.

Characteristics of bone turnover in the long bone metaphysis fractured patients with normal or low Bone Mineral Density (BMD).

Wolfl C, Schweppenhauser D, Guhring T, Takur C, Honer B, Kneser U PLoS One. 2014; 9(5):e96058.

PMID: 24788647 PMC: 4006874. DOI: 10.1371/journal.pone.0096058.

References

Ahlborg H, Johnell O, Turner C, Rannevik G, Karlsson M . Bone loss and bone size after menopause. N Engl J Med. 2003; 349(4):327-34. DOI: 10.1056/NEJMoa022464. View

Akesson K, Vergnaud P, Delmas P, Obrant K . Serum osteocalcin increases during fracture healing in elderly women with hip fracture. Bone. 1995; 16(4):427-30. View

Obrant K . Trabecular bone changes in the greater trochanter after fracture of the femoral neck. Acta Orthop Scand. 1984; 55(1):78-82. DOI: 10.3109/17453678408992317. View

Obrant K, Ivaska K, Gerdhem P, Alatalo S, Pettersson K, Vaananen H . Biochemical markers of bone turnover are influenced by recently sustained fracture. Bone. 2005; 36(5):786-92. DOI: 10.1016/j.bone.2005.02.009. View

Lill C, Gerlach U, Eckhardt C, Goldhahn J, Schneider E . Bone changes due to glucocorticoid application in an ovariectomized animal model for fracture treatment in osteoporosis. Osteoporos Int. 2002; 13(5):407-14. DOI: 10.1007/s001980200047. View

Garnero P, Delmas P . Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. J Musculoskelet Neuronal Interact. 2004; 4(1):50-63. View

Ivaska K, Gerdhem P, Akesson K, Garnero P, Obrant K . Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women. J Bone Miner Res. 2007; 22(8):1155-64. DOI: 10.1359/jbmr.070505. View

Ingle B, Hay S, Bottjer H, Eastell R . Changes in bone mass and bone turnover following ankle fracture. Osteoporos Int. 1999; 10(5):408-15. DOI: 10.1007/s001980050247. View

Mallmin H, Ljunghall S, Larsson K . Biochemical markers of bone metabolism in patients with fracture of the distal forearm. Clin Orthop Relat Res. 1993; (295):259-63. View

10.

Joerring S, Krogsgaard M, Wilbek H, Jensen L . Collagen turnover after tibial fractures. Arch Orthop Trauma Surg. 1994; 113(6):334-6. DOI: 10.1007/BF00426183. View

11.

Pagani F, Francucci C, Moro L . Markers of bone turnover: biochemical and clinical perspectives. J Endocrinol Invest. 2006; 28(10 Suppl):8-13. View

12.

Veitch S, Findlay S, Hamer A, Blumsohn A, Eastell R, Ingle B . Changes in bone mass and bone turnover following tibial shaft fracture. Osteoporos Int. 2005; 17(3):364-72. DOI: 10.1007/s00198-005-2025-y. View

13.

Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T . Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort. Mod Rheumatol. 2011; 21(6):608-20. DOI: 10.1007/s10165-011-0455-2. View

14.

Kurdy N . Serology of abnormal fracture healing: the role of PIIINP, PICP, and BsALP. J Orthop Trauma. 2000; 14(1):48-53. DOI: 10.1097/00005131-200001000-00010. View

15.

Hoshino H, Takahashi M, Kushida K, Ohishi T, Inoue T . Urinary excretion of type I collagen degradation products in healthy women and osteoporotic patients with vertebral and hip fractures. Calcif Tissue Int. 1998; 62(1):36-9. DOI: 10.1007/s002239900391. View

16.

Glover S, Garnero P, Naylor K, Rogers A, Eastell R . Establishing a reference range for bone turnover markers in young, healthy women. Bone. 2008; 42(4):623-30. DOI: 10.1016/j.bone.2007.12.218. View

17.

Garnero P . Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Mol Diagn Ther. 2008; 12(3):157-70. DOI: 10.1007/BF03256280. View

18.

Sato Y, Kaji M, Higuchi F, Yanagida I, Oishi K, Oizumi K . Changes in bone and calcium metabolism following hip fracture in elderly patients. Osteoporos Int. 2001; 12(6):445-9. DOI: 10.1007/s001980170088. View

19.

Claes L, Veeser A, Gockelmann M, Simon U, Ignatius A . A novel model to study metaphyseal bone healing under defined biomechanical conditions. Arch Orthop Trauma Surg. 2008; 129(7):923-8. DOI: 10.1007/s00402-008-0692-9. View

20.

Kurdy N, Bowles S, Marsh D, Davies A, France M . Serology of collagen types I and III in normal healing of tibial shaft fractures. J Orthop Trauma. 1998; 12(2):122-6. DOI: 10.1097/00005131-199802000-00010. View